Skip Nav Destination
Issues
1 March 2004
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Editorials
The Biology Behind
Featured Articles
Clinical Trials
Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia
James L. Mulshine; Jane C. Atkinson; Robert O. Greer; Vassiliki A. Papadimitrakopoulou; Carter Van Waes; Susan Rudy; Jack W. Martin; Seth M. Steinberg; David J. Liewehr; Ingalill Avis; R. Ilona Linnoila; Stephen Hewitt; Scott M. Lippman; Robin Frye; Paul F. Cavanaugh, Jr.
Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125: Immunological Response and Survival (Phase Ib/II)
Silke Reinartz; Siegmund Köhler; Harald Schlebusch; Karl Krista; Patrick Giffels; Kirsten Renke; Jens Huober; Volker Möbus; Rolf Kreienberg; Andreas duBois; Paul Sabbatini; Uwe Wagner
Molecular Oncology, Markers, Clinical Correlates
Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer
Sylke Schneider; JiMin Yochim; Jan Brabender; Kazumi Uchida; Kathleen D. Danenberg; Ralf Metzger; Paul M. Schneider; Dennis Salonga; Arnulf H. Hölscher; Peter V. Danenberg
Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Ulrich Keilholz; Petra Goldin-Lang; Nikolaos E. Bechrakis; Nicole Max; Anne Letsch; Alexander Schmittel; Carmen Scheibenbogen; Karin Heufelder; Alexander Eggermont; Eckhard Thiel
Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer
Wolfgang J. Köstler; Barbara Schwab; Christian F. Singer; Rainer Neumann; Ernst Rücklinger; Thomas Brodowicz; Sandra Tomek; Monika Niedermayr; Michael Hejna; Günther G. Steger; Michael Krainer; Christoph Wiltschke; Christoph C. Zielinski
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
A Randomized Phase I and Pharmacological Trial of Sequences of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and Temozolomide in Patients with Advanced Solid Neoplasms
Lisa A. Hammond; John R. Eckardt; John G. Kuhn; Stanton L. Gerson; Tom Johnson; Lon Smith; Ronald L. Drengler; Elizabeth Campbell; Geoffrey R. Weiss; Daniel D. Von Hoff; Eric K. Rowinsky
A Phase I and Pharmacokinetic Study of Irinotecan Given as a 7-Day Continuous Infusion in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil or Raltitrexed
Gianluca Masi; Alfredo Falcone; Antonello Di Paolo; Giacomo Allegrini; Romano Danesi; Cecilia Barbara; Samanta Cupini; Mario Del Tacca
Cancer Biology, Immunology, Cytokines
Interleukin 1β Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-κB Activation
Naoki Yamanaka; Takashi Morisaki; Hiroshi Nakashima; Akira Tasaki; Makoto Kubo; Hirotaka Kuga; Chihiro Nakahara; Katsuya Nakamura; Hirokazu Noshiro; Takashi Yao; Masazumi Tsuneyoshi; Masao Tanaka; Mitsuo Katano
Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells
Natalie Blaszczyk; Bassam A. Masri; Nasrin R. Mawji; Takeshi Ueda; Gavan McAlinden; Clive P. Duncan; Nicholas Bruchovsky; Hans-Udo Schweikert; Doris Schnabel; Edward C. Jones; Marianne D. Sadar
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients
Gottfried E. Konecny; Y. Gloria Meng; Michael Untch; He-Jing Wang; Ingo Bauerfeind; Melinda Epstein; Petra Stieber; Jean-Michel Vernes; Johnny Gutierrez; Kyu Hong; Malgorzata Beryt; Hermann Hepp; Dennis J. Slamon; Mark D. Pegram
Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas
Kwok Hung Yu; Y. M. Dennis Lo; Gary M. Tse; K. C. Allen Chan; Amy B. W. Chan; Katherine C. K. Chow; Tony K. F. Ma; Alexander C. Vlantis; Sing Fai Leung; C. Andrew van Hasselt; Philip J. Johnson; Anthony T. C. Chan
Allelic Loss of a Common Microsatellite Marker MYCL1: A Useful Prognostic Factor of Poor Outcomes in Colorectal Cancer
Takeshi Kambara; Gerald B. Sharp; Takeshi Nagasaka; Masanori Takeda; Hiromi Sasamoto; Hitoshi Nakagawa; Hiroshi Isozaki; Donald G. MacPhee; Jeremy R. Jass; Noriaki Tanaka; Nagahide Matsubara
[11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy
Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Takashi Tomemori; Kenji Sagou; Mei Tian; Susumu Kandatsu; Tadashi Kamada; Hiroshi Tsuji; Tetsuya Suhara; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Predictive Value of Biological Markers for Hepatocellular Carcinoma Patients Treated with Orthotopic Liver Transplantation
Michelangelo Fiorentino; Annalisa Altimari; Matteo Ravaioli; Elisa Gruppioni; Elena Gabusi; Barbara Corti; Marco Vivarelli; Pierre-Paul Bringuier; Jean-Yves Scoazec; Walter Franco Grigioni; Antonia D’Errico-Grigioni
Experimental Therapeutics, Preclinical Pharmacology
Blockage of 2-Deoxy-d-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy
Hendrik Seeliger; Markus Guba; Gudrun E. Koehl; Axel Doenecke; Markus Steinbauer; Christiane J. Bruns; Christine Wagner; Erika Frank; Karl-Walter Jauch; Edward K. Geissler
Advertisement
